Matthew B. Stanbrook, MD, PhD
Stanbrook MB. In symptomatic COPD, once-daily triple vs dual therapy reduced moderate or severe exacerbations at 1 year. Ann Intern Med. 2018;169:JC16. doi: https://doi.org/10.7326/ACPJC-2018-169-4-016
Download citation file:
Published: Ann Intern Med. 2018;169(4):JC16.
Chronic Obstructive Airway Disease, Pulmonary/Critical Care.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use